Express Scripts Inc. will buy health insurer WellPoint Inc.’s NextRx prescription business for $4.68 billion, giving the pharmacy benefit manager more leverage in driving down drug prices and in competing against its larger rivals.
*For more on this story,
read the full Reuters article.
